2021
DOI: 10.1016/j.parkreldis.2020.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Spinal cord stimulation improves motor function and gait in spastic paraplegia type 4 (SPG4): Clinical and neurophysiological evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 14 publications
0
7
0
Order By: Relevance
“…De Souza et al ( 8 ) reported a subject who underwent chronic spinal cord stimulation (SCS) implantation in the posterior epidural space of T11–T12. Alternating ON/OFF phases allowed studying the effect of SCS: improvements in muscle strength and spasticity and at SPRS were reported in ON phases.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…De Souza et al ( 8 ) reported a subject who underwent chronic spinal cord stimulation (SCS) implantation in the posterior epidural space of T11–T12. Alternating ON/OFF phases allowed studying the effect of SCS: improvements in muscle strength and spasticity and at SPRS were reported in ON phases.…”
Section: Resultsmentioning
confidence: 99%
“…Depending on the presence or absence of a family history of spastic paraparesis and the results of genetic testing, the disease is named HSP or SSP, as sporadic ( 6 ). The genetic basis of HSP is complex, with more than 70 known subtypes involving autosomal, dominant or recessive, and X-linked inheritance patterns ( 1 , 7 ), causing dysfunction of protein involved in intracellular trafficking or mitochondrial function ( 7 , 8 ). The age of symptom onset, rate of progression, and degree of disability are often variable among different genetic types of HSP, as well as within individual families having the same gene mutation ( 6 , 9 , 10 ).…”
Section: Introductionmentioning
confidence: 99%
“…It indicates that the motor neurons and motor pathways associated with the upper extremity muscles were activated, which may make the upper extremity motions more flexible and indirectly create favorable conditions for improving the patient's walking stability. Previous studies suggested that the activity motor cortical areas might improve gait by inducing activity modulation of spared descending motor pathways ( 38 , 39 ). Furthermore, a slight decrease in CMCT in the upper extremities compared to the pre-treatment indicates an increase in the conduction velocity of upper motor neurons, which may reflect improved axonal performance in the fast-conducting fibers of corticospinal neurons ( 40 ).…”
Section: Discussionmentioning
confidence: 99%
“…Loss of function and consequent haploinsu ciency have been the most plausible pathogenic mechanisms to explain HSP-SPG4 onset, truncating mutations are the most frequent cause of HSP-SPG4, it predominantly affect the enzymatic activity of the spastin domain, thus reducing its ATPase activity. Moreover, it was shown that missense mutations outside the AAA domain lead the M1 isoform of spastin to negatively interact with spastin-M87, diminishing its microtubule-severing activity [27][28][29] .…”
Section: Discussionmentioning
confidence: 99%
“…Botulinum toxin type A and intensive physiotherapy can lead to improvement of spasticity and quality of life in patients with HSP-SPG4 [33] . The electrical stimulation of spinal nerve has a positive effect on improving weakness and spastic gait in SPG4 patients [29] . Selective dorsal rhizotomy is currently recognized as the most effective method for lasting relief of limb spasm, reducing the risk of disuse muscular atrophy of SPG4 patients [34] .…”
Section: Declarations Fundingmentioning
confidence: 98%